Vancomycin-resistant enterococcal bacteremia: Comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis

Journal of Microbiology, Immunology and Infection

Volumn 41, Issue 2, 2008, Pages 124-129

  Chou, Yen Yi ^a   Lin, Te Yu ^a   Lin, Jung Chung ^a   Wang, Ning Chi ^a   Peng, Ming Yieh ^a   Chang, Feng Yee ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Bacteremia; Enterococcus faecalis; Enterococcus faecium; Vancomycin resistance

Indexed keywords

AMPICILLIN; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BONE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EXPOSURE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; SKIN; SOFT TISSUE; STATISTICAL SIGNIFICANCE; TAIWAN; TOTAL HIP PROSTHESIS; URINARY TRACT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; TAIWAN; TREATMENT OUTCOME; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 48649085107     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Thouverez M, Talon D. Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France. Clin Microbiol Infect. 2004;10:441-7.
2. Chavers LS, Moser SA, Benjamin WH, Banks SE, Steinhauer JR, Smith AM, et al. Vancomycin-resistant enterococci: 15 years and counting. J Hosp Infect. 2003;53:159-71.
3. Bonafede M, Rice LB. Emerging antibiotic resistance. J Lab Clin Med. 1997;130:558-66.
4. Jean SS, Fang CT, Wang HK, Hsueh PR, Chang SC, Luh KT. Invasive infections due to vancomycin-resistant enterococci in adult patients. J Microbiol Immunol Infect. 2001;34:281-6.
5. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 15th informational supplement. CLSI document M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
6. National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 6th ed. NCCLS document M7-A6. Wayne, PA: National Committee for Clinical Laboratory Standards; 2005.
7. Song X, Srinivasan A, Plaut D, Perl TM. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol. 2003;24:251-6.
8. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis. 1998;26:1127-33.
9. Montecalvo MA, Shay DK, Patel P, Tacsa L, Maloney SA, Jarvis WR, et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med. 1996;156:1458-62.
10. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995;20:1126-33.
11. Centers for Disease Control and Prevention (CDC). Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993;42: 597-9.
12. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000;342:710-21.
13. Gold HS. Vancomycin-resistant enterococci: mechanisms and clinical observations. Clin Infect Dis. 2001;33:210-9.
14. Yeh KM, Lu JJ, Siu LK, Peng MY, Chang FY. Phenotypes and genotypes of vancomycin-resistant enterococci isolated during long-term follow-up in a patient with recurrent bacteremia and colonization. J Microbiol Immunol Infect. 2002;35:243-8.
15. Yeh KM, Siu LK, Chang JC, Chang FY. Vancomycin-resistant enterococcus (VRE) carriage and infection in intensive care units. Microb Drug Resist. 2004;10:177-83.
16. Noskin GA. Vancomycin-resistant enterococci: clinical, microbiologic, and epidemiologic features. J Lab Clin Med. 1997;130:14-20.
17. Zirakzadeh A, Patel R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc. 2006;81:529-36.
18. Weber DJ, Rutala WA. Role of environmental contamination in the transmission of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 1997;18:306-9.
19. Perl TM. The threat of vancomycin resistance. Am J Med. 1999;106:26S-37S.
20. Ena J, Dick RW, Jones RN, Wenzel RP. The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. JAMA. 1993;269:598-602.
21. Wells CL, Maddaus MA, Jechorek RP, Simmons RL. Role of intestinal anaerobic bacteria in colonization resistance. Eur J Clin Microbiol Infect Dis. 1988;7:107-13.
22. Wells CL, Maddaus MA, Reynolds CM, Jechorek RP, Simmons RL. Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect Immun. 1987;55:2689-94.
23. Wells CL, Jechorek RP, Maddaus MA, Simmons RL. Effects of clindamycin and metronidazole on the intestinal colonization and translocation of enterococci in mice. Anti-microb Agents Chemother. 1988;32:1769-75.
24. Quale J, Landman D, Atwood E, Kreiswirth B, Willey BM, Ditore V, et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control. 1996;24:372-9.